F5 (FFIV) insider sale: 1,300 shares at $320.61

Locoh-Donou Francois, who serves as President, CEO & Director of F5, Inc. (FFIV), reported a sale of 1,300 shares of the company's common stock on 10/01/2025 at a reported price of $320.61 per share.

Rhea-AI Filing Summary

Locoh-Donou Francois, who serves as President, CEO & Director of F5, Inc. (FFIV), reported a sale of 1,300 shares of the company's common stock on 10/01/2025 at a reported price of $320.61 per share. After the transaction, Mr. Locoh-Donou beneficially owned 107,553 shares directly and 42,000 shares indirectly through a family trust. The filing indicates the sale was executed pursuant to a Rule 10b5-1 trading plan dated 11/13/2024. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person on 10/03/2025. The document contains only the disclosed insider sale and current beneficial ownership figures.

Insider Trade Summary

Net Seller: 1,300 shares

Net Sell 2 txns

Insider Locoh-Donou Francois

Role President, CEO & Director

Sold 1,300 shs ($417K)

Type	Security	Shares	Price	Value
Sale	Common Stock	1,300	$320.61	$417K
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 107,553 shares (Direct); Common Stock — 42,000 shares (Indirect, By Family Trust)

Footnotes (1)

1. F1. This transaction was executed pursuant to a Rule 10b5-1 trading plan dated 11/13/2024.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did F5 (FFIV) report on this Form 4?

The filing reports a sale of 1,300 shares of F5 common stock on 10/01/2025 at $320.61 per share.

Who is the reporting person on the Form 4 for FFIV?

The reporting person is Locoh-Donou Francois, identified as President, CEO & Director of F5, Inc.

How many F5 shares does the reporting person own after the reported transaction?

Following the reported sale, the reporting person beneficially owned 107,553 shares directly and 42,000 shares indirectly via a family trust.

Was the sale executed under a prearranged plan?

Yes. The sale was executed pursuant to a Rule 10b5-1 trading plan dated 11/13/2024, as noted in the filing.

Who signed the Form 4 and when?

The Form 4 was signed by Angelique M. Okeke by Power of Attorney on 10/03/2025.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 10/03/2025 - 05:14 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Locoh-Donou Francois

(Last) (First) (Middle)

C/O F5, INC.

801 5TH AVENUE

(Street)

SEATTLE WA 98104

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
F5, INC. [ FFIV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President, CEO & Director

3. Date of Earliest Transaction (Month/Day/Year)
10/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/01/2025		S		1,300(1)	D	$320.61	107,553	D
Common Stock								42,000	I	By Family Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This transaction was executed pursuant to a Rule 10b5-1 trading plan dated 11/13/2024.

Remarks:

	/s/ Angelique M. Okeke by Power of Attorney	10/03/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.